Glaxosmithkline | GSK - Capital Y Las Reservas

Precio De Mercado
58.97
Cambio Diario
-0.15 -0.25%
Mensual
-0.49%
Anual
70.24%
Q2 Expectativa
57.14




Capital Y Las Reservas Cambio Fecha
AbbVie USD -3.27B 628M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bausch Health Companies USD -554M 910M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 22.06B 360M 2025-12
J&J USD 78.47B 0 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Pacira USD 693.11M 34.1M 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Zoetis USD 3.33B 2.07B 2025-12